Category: In the media

Holographic education

Dr Kapil Sugand graduated from Imperial College in 2010 with an intercalated BSc in Surgery & Anaesthesia. On behalf of MSk Lab, Dr Sugand has represented at public engagement events on simulation.

Alongside clinical training, Dr Sugand is currently pursuing a PhD in surgical trauma simulation and educational technology under the supervision of Mr Gupte & Prof Cobb.  He is currently conducting research with a multi-disciplinary team within the following multimedia modalities to train safer surgeons and to ultimately enhance patient safety:

Holograms have the power to visually communicate with greater immersive impact than other presentation modalities so that patients may be able to understand the disease process and management options more effectively.

Technology and Outcomes in Arthroplasty

Professor Cobb was invited to write an article for Issue 4 of Orthopaedics Today Europe about the role technology has in orthopaedic surgery and if it does indeed make a difference in outcomes – “Technology can make a difference in outcomes for most arthroplasty Luddites”. There have been a number of discussions in medical journals the last few months about technology and the role of robotics in surgery; however this article gives a plotted history of how surgical tools have developed over the last 20 years and the impact they have had.

The article concludes with Professor Cobb summarising;

Only two things are required from surgical technology: a precise plan of surgery, including the size of the devices needed and exactly where they should go, and a timely and cost-effective way of carrying out the plan.

Having a new hip can boost your brain power

In the 19th June edition of the Daily Mail, Dr Paul Strutton was asked to make comment on the decline of grey matter in people with chronic pain, in an article titled: Having a new hip can boost your brain power: Relieving chronic pain improves your mind as well as your body.

Dr Paul Strutton, senior lecturer in neurophysiology at Imperial College London, adds: ‘There is now good evidence to show grey matter declines in people with chronic pain.

‘We think the plasticity that occurs in the brain is as a result of the pain and not a cause of it.

‘The big question is whether this loss of nerve cells in the grey matter can be reduced or even reversed by treating the pain.’

Research into the area continues: a clinical trial is starting this month at North Western University in which 60 men and women with knee osteoarthritis will be given either a drug called duloxetine, widely used to treat pain, or a sugar pill.